CCND1 and synovial sarcoma: In contrast to the previous study that only investigated cyclin D1 and pRb levels following palbociclib treatment27, we specifically knocked down CDK4 expression with CDK4 siRNAs to investigate the role of CDK4 in synovial sarcoma cell growth and proliferation.